DARA BioSciences, Inc. Announces Launch of Bionect for Treatment of Skin Irritation and Burns Associated With Radiation Therapy for Cancer

Published: Jun 06, 2012

RALEIGH, N.C., June 6, 2012 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA) (the "Company" or "DARA"), an emerging oncology and oncology-support specialty pharmaceutical company, announced the commercial launch of Bionect® for the treatment of skin irritation and burns associated with radiation therapy.

Back to news